SS Innovations International (SSII) Return on Capital Employed (2017 - 2026)
SS Innovations International (SSII) reported Return on Capital Employed of 10.85% for Q1 2026, up 2888.0% on a YoY basis from 0.36% in Q1 2025, and up 41.0% sequentially from 18.39% in Q4 2025.
SS Innovations International (SSII) Return on Capital Employed (2017 - 2026) Analysis & Trends
SS Innovations International (SSII) has 10 years of Return on Capital Employed data on file, last reported at 10.85% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 2888.0% year-over-year to 10.85%; the trailing twelve-month figure through Mar 2026 stood at 10.85% (up 2888.0% YoY), and the FY2025 full-year result was 25.56%, up 9593.0% from the prior year.
- Return on Capital Employed climbed to 10.85% in Q1 2026, from 18.39% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 449.97% in Q3 2022 to a low of 1549.84% in Q2 2022.
- A 5-year average of 236.35% and a median of 94.91% in 2023 frame the typical range for Return on Capital Employed.
- Peak annual rise in Return on Capital Employed reached 163639 bps in 2022, while the deepest fall reached 170485 bps in 2022.
- Tracing SSII's Return on Capital Employed over 5 years: stood at 61.07% in 2022, then sank by 255 bps to 94.91% in 2023, then slipped by 3 bps to 97.95% in 2024, then jumped by 81 bps to 18.39% in 2025, then surged by 41 bps to 10.85% in 2026.
- Business Quant data shows SSII's Return on Capital Employed at 10.85% in Q1 2026, 18.39% in Q4 2025, and 19.55% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | -10.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.85% |
| Dec 31, 2025 | -18.39% |
| Sep 30, 2025 | -19.55% |
| Jun 30, 2025 | -23.07% |
| Mar 31, 2025 | -39.73% |
| Dec 31, 2024 | -97.95% |
| Sep 30, 2024 | -155.46% |
| Jun 30, 2024 | -136.61% |
| Mar 31, 2024 | -142.85% |
| Dec 31, 2023 | -94.91% |
| Sep 30, 2023 | -76.25% |
| Jun 30, 2023 | -827.05% |
| Mar 31, 2023 | -280.50% |
| Dec 31, 2022 | 61.07% |
| Sep 30, 2022 | 449.97% |
| Jun 30, 2022 | -1,549.84% |
| Mar 31, 2022 | -1,056.08% |
| Dec 31, 2021 | -1,575.32% |
| Sep 30, 2021 | 152.16% |
| Jun 30, 2021 | 155.01% |